Symbol="PSTX"
AssetType="Common Stock"
Name="Poseida Therapeutics Inc"
Description="Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with high unmet medical needs. The company is headquartered in San Diego, California."
CIK="1661460"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="9390 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="228220000"
EBITDA="-23375000"
PERatio="None"
PEGRatio="None"
BookValue="1.557"
DividendPerShare="0"
DividendYield="0"
EPS="-0.36"
RevenuePerShareTTM="1.868"
ProfitMargin="-0.186"
OperatingMarginTTM="-0.184"
ReturnOnAssetsTTM="-0.074"
ReturnOnEquityTTM="-0.29"
RevenueTTM="156713000"
GrossProfitTTM="-22407000"
DilutedEPSTTM="-0.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.41"
AnalystTargetPrice="11.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.525"
PriceToBookRatio="2.265"
EVToRevenue="1.988"
EVToEBITDA="-16.1"
Beta="0.121"
num_52WeekHigh="8.82"
num_52WeekLow="1.54"
num_50DayMovingAverage="2.07"
num_200DayMovingAverage="4.022"
SharesOutstanding="86776000"
DividendDate="None"
ExDividendDate="None"
symbol="PSTX"
open="2.54"
high="2.69"
low="2.43"
price="2.63"
volume="548061.00"
latest_trading_day="2023-08-17"
previous_close="2.54"
change="0.09"
change_percent="3.5433%"
aroon_positive_momentum_days="5"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="5"
Volume_recent_avg="1006298"
Change_recent_avg="-0.02"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.95"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="5"
Aroon_momentum_negative="95"
image_negative_thumbnail_id_1="1163"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="579"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="646"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_positive_thumbnail_id_2="701"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
